Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index.

Published in: Risk management and healthcare policy (2021)

NOACs can be a promising thromboprophylactic option in both male and female cancer patients with VTE risk.

Keyphrases